4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-25-108210
Chief Development Officer sold 22,073 shares at $5.15 ($113,713)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Machatha Stephen Chief Development Officer | 2025-08-11 | Sale | −22,073 | $5.15 | $113,713 | 221,799 | D |
| Open-market sales · 22,073 sh · avg $5.15 · $113,713 | |||||||
Loading xslF345X05/ownership.xml…